medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2007, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2007; 5 (4)

Lucio’s Phenomenon in a Patient with Lepromatose Leprosy

Poletti ED, García CA, Márquez DF

Language: Spanish
References: 22
Page: 205-210
PDF size: 636.68 Kb.


ABSTRACT

56 y/o patient with diffuse lepromatous leprosy since age 29 developed fever, lymphadenopathy, and organo- megaly. She exhibited a painful purpuric patches, multiple erythematous to violaceous macules, involving with symmetrical distribution all the extremities, that become necrotic and ulcerated and leave scars.
In the beginning, not lesions were noted on the upper body an there was no palmar or plantar involvement.The mucous membranes did not appear to be involved. On cutaneous biopsy, we observed vasculitic and thrombotic reaction. Patient did not respond to systemic steroids, pentoxyfilina and dapsone and died later of multi-organ failure for sepsis.


REFERENCES

  1. Moschella SL, An update on the diagnosis and treatment of leprosy. J Am Acad Derm. 2004 ; 51: 417-426.

  2. Moschella SL. The lepra reaction with necrotizing skin lesions: a report of six cases. Arch Dermatol. 1967; 95: 565-575.

  3. Iglesias Diez L., Guerra-Tapia A., Ortiz-Romero PL. Tratado de Der ma - to logía. 1a ed., Madrid: Mc Graw Hill-Interamericana, 2004: 127-136.

  4. Arenas R. Atlas Dermatología diagnóstico y tratamiento. 3a ed. México: Mc Graw Hill, 2004: 336-351.

  5. Saúl A. Lecciones de Dermatología. 14a ed. México: Méndez Editores, 2001: 123-199.

  6. Jacobson RR, Krahenbuhl JL. Leprosy. Lancet. 1999; 353: 655-660.

  7. Torres-Lozada V, et al.Dermatología Práctica Ibero-Latinoamericana. 1a. ed. México: Nieto Editores, 2005: 194-212.

  8. Firooz, A. Multidrug therapy regimen for leprosy. J Am Acad Derm. December 2006; 55: 115.

  9. Rea TH, Levan NE. Lucio’s phenomenon and diffuse non nodular leproma- tous leprosy. Arch Dermatol. 1978; 1114: 1023-1028.

  10. Purseley TV, Jacobsen RR, Apisarnthanarax P. Lucio’s phenomenon. Arch Dermatol. 1980; 116: 201-204.

  11. Compa FV, Cabrini JM, Arpini RH, Vacirca EE, Recarte MC, Chapo R. The Lucio phenomenon. Leprologica. 1981; 23: 57-59.

  12. Lucio R, Alvarado I. Opúsculo sobre el mal de San Lázaro o elefanciasis de los griegos. Mexico: M. Murgía y Cía; 1852; 53.

  13. Latapí F. Lepra. Resúmen de lecciones dictadas en el curso de Dermatología Tropical. Prensa Med Mex. 1946; 11: 1-47.

  14. Latapí F, Chevez ZA. The “spotted” leprosy of Lucio (La lepra “manchada” de Lucio): an introduction to its clinical and histological study. Int J Lepr. 1948; 16: 421-429.

  15. Halabe-Cherem J, Vera-Lastra O, Poletti-Vázquez E. “Vasculitis”, en Paniculitis-Vasculitis. 1a ed. México: Alfil, 117-134.

  16. Seghal VN, Srivasta G, Sharma VK. Contemplative immune mechanism of Lucio phenomenon and its global status. J Dermatol. 1987; 14: 580-586.

  17. Moschella SL. Primary diffuse lepromatous leprosy with erythema necroticans (Lucio phenomenon). Arch Dermatol. 1968; 97: 593-596.

  18. Fasal P. Diffuse lepromatosis with erythema necroticans. Arch Dermatol. 1962; 87: 535.

  19. Hernandez FG, Rosa JN, Serra AJ, Rey JP. Diffuse painless ulcerations. Arch Dermatol. 1999; 135: 983-988

  20. Sheskin J. Diffuse lepromatosis of Lucio-Alvarado-Latapi with Lucio pheno- menon: first case in the Near East. Rev Leprol. 1982; 13: 651-656.

  21. Yong-Kwang Tay, A. See-Ket Ng, Chew-Swee S. Fatal Lucio’s pheno- menon in 2 patients with previously undiagnosed leprosy. J Am Acad Derm. 2003; 48: 958-961.

  22. Rodríguez, O. La leprología al inicio del Siglo XXI. Revista del Centro Dermatólógico Pascua. Sept- Dic. 2006. Vol 15, Número 3. 135-148.




2020     |     www.medigraphic.com